2021 uroLogic Conference
140 - Corporate Luncheon Product Theater - Important Evidence-Based Changes in the Metastatic Castration-Sensitive Prostate Cancer Treatment Landscape (Sponsored by Astellas Pharma, US, Inc. and Pfizer Oncology)
Oct 29, 2021 12:30pm ‐ Oct 29, 2021 1:45pm
Kathy D. Burns
, AGACNP-BC, MSN, OCN
You must be logged in and own this session in order to post comments.
© 2021 Digitell, Inc. All Rights Reserved